Array BioPharma Inc (ARRY)

8.21
0.29 3.66
NASDAQ : Health Care
Prev Close 7.92
Open 7.92
Day Low/High 7.81 / 8.30
52 Wk Low/High 2.38 / 6.56
Volume 3.14M
Avg Volume 6.90M
Exchange NASDAQ
Shares Outstanding 168.55M
Market Cap 1.37B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Shark Bites: Market Responds With 'Deutsche Who?'

Report of settlement turns the market.

Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success

Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success

Following the success of Array BioPharma's (ARRY) melanoma treatment in a clinical trial announced yesterday, JPMorgan increased its price target on the stock.

Futures Swing Into Positive Territory During Debate, Asia Lower

Futures Swing Into Positive Territory During Debate, Asia Lower

Debate switches futures into positive territory after down day on Wall Street.

Noteworthy Monday Option Activity: ARRY, LLNW, LE

Noteworthy Monday Option Activity: ARRY, LLNW, LE

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Array BioPharma Inc. , where a total volume of 19,126 contracts has been traded thus far today, a contract volume which is representative of approximately 1.9 million underlying shares (given that every 1 contract represents 100 underlying shares).

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

Here's a technical look at how to trade some of the most active stocks on the market right now.

Shark Bites: Not Much Reason to Buy in This Environment

I'm even staying away from the appealing stocks.

Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target

Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target

Array BioPharma (ARRY) announced on Monday that the company's treatment for metastatic melanoma met its primary endpoint in a late-stage clinical trial.

Putting 2 Biotechs Under the Microscope

These low-dollar biotech stocks are making big moves Monday -- in opposite directions.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

First Week of ARRY November 18th Options Trading

First Week of ARRY November 18th Options Trading

Investors in Array BioPharma Inc. saw new options become available this week, for the November 18th expiration.

Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies

Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies

Jefferies upped its price target on Array BioPharma (ARRY) to $7 earlier today.

Short Interest Moves 13.5% Lower For ARRY

Short Interest Moves 13.5% Lower For ARRY

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 2,190,797 share decrease in total short interest for Array BioPharma Inc. , to 14,071,789, a decrease of 13.47% since 07/29/2016.

Interesting ARRY Put And Call Options For October 21st

Interesting ARRY Put And Call Options For October 21st

Investors in Array BioPharma Inc. saw new options begin trading today, for the October 21st expiration.

Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial

Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial

Array BioPharma (ARRY) stock was tumbling in late-afternoon trading after the company's cancer drug trial failed to meet its primary endpoint.

Array BioPharma (ARRY) Trading With Heavy Volume Before Market Open

Array BioPharma (ARRY) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Array BioPharma (ARRY) as a pre-market mover with heavy volume candidate

5 Best-Positioned Biotech Stocks on Brexit Volatility

5 Best-Positioned Biotech Stocks on Brexit Volatility

Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

First Week of December 16th Options Trading For Array BioPharma (ARRY)

First Week of December 16th Options Trading For Array BioPharma (ARRY)

Investors in Array BioPharma Inc. saw new options begin trading this week, for the December 16th expiration.

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Six patients, all with TRK fusion cancers unresponsive to current therapies, reported tumor shrinkage following treatment with Loxo's drug LOXO-101.

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Strong On High Volume Today

Array BioPharma (ARRY) Is Strong On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Investors eyeing a purchase of Array BioPharma Inc. stock, but tentative about paying the going market price of $3.19/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Short Interest In Array BioPharma Moves 10.3% Lower

Short Interest In Array BioPharma Moves 10.3% Lower

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 2,674,046 share decrease in total short interest for Array BioPharma Inc. , to 23,339,973, a decrease of 10.28% since 12/15/2015.